Drugmakers Call Experimental Alzheimer's Drug Study Positive

Biogen and Japan’s Eisai said they had positive results from a midstage study of an experimental Alzheimer’s drug, though experts said it was too soon to say the drug marks a real advance.
Source: Wall Street